Central effects of neuromedin U in the regulation of energy homeostasis.

Neuromedin U (NMU) is a brain-gut peptide whose peripheral activities are well-understood but whose central actions have yet to be clarified. The recent identification of two NMU receptors in rat brain has provided a springboard for further investigation into its role in the central nervous system. Intracerebroventricular administration of NMU to free-feeding rats decreased food intake and body weight. Conversely, NMU increased gross locomotor activity, body temperature, and heat production. NMU, a potent endogenous anorectic peptide, serves as a catabolic signaling molecule in the brain. Further investigation of the biochemical and physiological functions of NMU will help our better understanding of the mechanisms of energy homeostasis.

[1]  O. Nishimura,et al.  Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled Receptor FM-3* , 2000, The Journal of Biological Chemistry.

[2]  J. Chambers,et al.  Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3* , 2000, The Journal of Biological Chemistry.

[3]  Christopher P. Austin,et al.  Identification of receptors for neuromedin U and its role in feeding , 2000, Nature.

[4]  M. Nakazato,et al.  Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats , 1999, Brain Research.

[5]  A. Howard,et al.  Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. , 1998, Genomics.

[6]  O. Civelli.  Functional genomics: the search for novel neurotransmitters and neuropeptides , 1998, FEBS letters.

[7]  Hirokazu Matsumoto,et al.  A prolactin-releasing peptide in the brain , 1998, Nature.

[8]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[9]  N. Murakami,et al.  Daily injections of melatonin entrain the circadian activity rhythms of nocturnal rats but not diurnal chipmunks , 1997, Brain Research.

[10]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[11]  R. Idzerda,et al.  Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A , 1996, Nature.

[12]  B. Spiegelman,et al.  Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. , 1995, The Journal of clinical investigation.

[13]  J. Warchoł,et al.  Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland , 1994, Neuropeptides.

[14]  B. Lowell,et al.  Development of obesity in transgenic mice after genetic ablation of brown adipose tissue , 1993, Nature.

[15]  P. Abel,et al.  Primary structure and pharmacological activity of a nonapeptide related to neuromedin U isolated from chicken intestine , 1991, Peptides.

[16]  Y. Yiangou,et al.  The distribution, purification, and pharmacological action of an amphibian neuromedin U. , 1989, The Journal of biological chemistry.

[17]  D. Brown,et al.  Neuromedin U octapeptide alters ion transport in porcine jejunum. , 1988, European journal of pharmacology.

[18]  J. Polak,et al.  Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat , 1988, Neuroscience.

[19]  S. Sumi,et al.  Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal cord, on splanchnic circulation in dogs. , 1987, Life sciences.

[20]  N. Minamino,et al.  Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. , 1985, Biochemical and biophysical research communications.